Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 14, 2024

SELL
$0.53 - $3.25 $159 - $975
-300 Closed
0 $0
Q1 2022

Aug 14, 2024

BUY
$0.75 - $1.77 $225 - $531
300 New
300 $236,000
Q3 2021

Aug 30, 2024

SELL
$2.91 - $4.83 $873 - $1,449
-300 Reduced 40.0%
450 $1.35 Million
Q2 2021

Aug 30, 2024

BUY
$4.17 - $5.74 $3,127 - $4,305
750 New
750 $3.5 Million
Q1 2021

Aug 30, 2024

SELL
$5.28 - $9.64 $2,904 - $5,302
-550 Reduced 42.31%
750 $3.96 Million
Q3 2020

Aug 30, 2024

SELL
$4.9 - $7.12 $2,205 - $3,204
-450 Reduced 25.71%
1,300 $7.94 Million
Q2 2020

Aug 30, 2024

SELL
$6.43 - $9.86 $1,286 - $1,972
-200 Reduced 10.26%
1,750 $12.7 Million
Q1 2020

Aug 30, 2024

SELL
$6.36 - $10.05 $1,272 - $2,010
-200 Reduced 9.3%
1,950 $13.6 Million
Q4 2019

Aug 30, 2024

SELL
$8.49 - $12.81 $5,518 - $8,326
-650 Reduced 23.21%
2,150 $19 Million
Q3 2019

Aug 30, 2024

SELL
$5.58 - $14.47 $7,533 - $19,534
-1,350 Reduced 32.53%
2,800 $31.4 Million
Q2 2019

Aug 30, 2024

SELL
$5.22 - $9.08 $2,610 - $4,540
-500 Reduced 10.75%
4,150 $25.1 Million
Q4 2018

Aug 30, 2024

BUY
$3.43 - $6.19 $15,949 - $28,783
4,650 New
4,650 $23.1 Million
Q3 2018

Aug 30, 2024

SELL
$4.75 - $14.5 $13,775 - $42,050
-2,900 Reduced 36.71%
5,000 $23.8 Million
Q2 2018

Aug 30, 2024

SELL
$13.3 - $17.45 $30,590 - $40,135
-2,300 Reduced 22.55%
7,900 $107 Million
Q1 2018

Aug 30, 2024

SELL
$14.7 - $24.95 $11,392 - $19,336
-775 Reduced 7.06%
10,200 $164 Million
Q4 2017

Aug 30, 2024

SELL
$19.9 - $29.25 $37,611 - $55,282
-1,890 Reduced 14.69%
10,975 $255 Million
Q3 2017

Aug 30, 2024

BUY
$15.1 - $19.25 $10,570 - $13,475
700 Added 5.75%
12,865 $237 Million
Q2 2017

Aug 30, 2024

BUY
N/A
12,165
12,165 $248 Million

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.